How COVID-19 Has Changed the Medical Cannabis Industry
In 1996, California became the first state to legalize medical marijuana.
In the decades since, cannabis legalization has expanded to 33 states and the District of Columbia.
Today, more than 60% of the U.S. population lives in states where medical cannabis is legal. And it’s estimated that as many as 115 million people have ailments that could potentially be treated by the medicine.
The country has been on lockdown for the past two months because of COVID-19. And we know the devastating effect that’s having on the broader economy.
But investors also want to know what impact that’s having on the cannabis industry.
So I reached out to our repeat guest Dr. Jordan Tishler, president of the Association of Cannabis Specialists and founder of InhaleMD, to share his insights from the front lines.
We discuss what changes he’s seen in prescribing cannabis since the pandemic began. And he explains what the potential permanent effects of COVID-19 could be on the industry. He also talks about whether inhalation is more dangerous now, since the coronavirus is infecting people’s lungs.
Dr. Tishler has always gladly shared his knowledge and wisdom with viewers. And in this video, he once again gives us an honest, thoughtful look at medical cannabis in the current and post-COVID-19 world.
Here’s to high returns,
About Matthew Carr
Matthew’s expertise ranges from classic industries such as oil and mining to cutting-edge markets like small cap tech, cannabis, 3D printing and cloud computing. With almost two decades of financial experience under his belt, Matthew’s knack for finding market trends never fails to surprise us, which is why we keep a close eye on his free e-letter, Profit Trends.